A Dutch company with a novel business model, Avanzanite Bioscience, is looking to expand patient access to medicines for rare diseases in Europe. 15 November 2022
Roman contract development and manufacturing organization (CDMO) ReiThera is set to open a new viral vector production area at its facility in Italy. 3 November 2022
A new pilot program has been announced by the US Food and Drug Administration, aimed at facilitating readiness for certain products with accelerated clinical de 1 November 2022
Swiss drugmaker Roche has revealed new long-term data for Ocrevus (ocrelizumab), related to disease progression and healthcare costs in people with early-stage 27 October 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.